文献速递功能神经外科神经重症

感染鞘内泵同台取出与对侧新泵植入病例系列

Simultaneous explantation and implantation of intrathecal pumps: a case series.
PubMed 文献 · J Neurosurg · 2019-04-12

该回顾性病例系列分析17例因鞘内药物输注装置(IDDD)感染而接受同台取出感染泵并在对侧植入新泵的患者,3年内无新植入泵或导管感染,感染均最终完全消退,中位住院7天,94.1%患者出院时护理级别与术前相近。

要点

  • 同台取出感染泵并植入新泵后无新泵或导管感染发生。
  • 感染均获完全消退,多数患者出院时护理级别与术前相近。
  • 5个月内29.4%患者需再次手术,包括脑脊液漏与旧泵部位感染。

核心结论

  • 同台取出感染IDDD并在对侧植入新泵(Turner Switch技术)可有效治疗IDDD感染,未出现新植入泵或导管感染,感染均完全消退。

研究设计与样本

  • 回顾性病例系列,分析3年期间17例因IDDD感染接受同台取出与植入的患者(11男6女)。

主要发现

  • 17例中14例(82.4%)为巴氯芬泵治疗痉挛,3例(17.6%)为芬太尼泵治疗慢性疼痛。
  • 无患者出现新植入泵或导管感染,所有患者初始感染最终完全消退。
  • 中位住院7天,16/17(94.1%)出院回家或护理级别与术前相近的机构。
  • 5例(29.4%)在5个月内重返手术室:2例脑脊液漏修补、2例旧泵部位感染、1例脑脊液漏合并感染。

临床怎么用

  • 对IDDD深部感染,可考虑同台取出感染泵并在对侧植入新泵,以避免长期住院和药物撤退风险。
  • 术后需关注脑脊液漏和旧泵部位感染,本系列中29.4%患者5个月内再次手术。

局限性

  • 回顾性设计、样本量小(17例)、单中心经验,缺乏对照组,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Intrathecal drug delivery devices (IDDDs) are a mainstay in the treatment of spasticity and refractory pain. While these devices have been shown to greatly improve the quality of life for patients, they also have a high perioperative complication and failure rate. A major complication of IDDD implantation is infection. The current standard of care in the treatment of IDDD infection necessitates that the pump be explanted and the infection treated prior to implantation of a new IDDD. This process leads to long hospital stays, interruptions in optimal medical management, and a high risk for dangerous drug withdrawals. The authors describe a technique that allows for the explantation of the infected pump and implantation of a new pump concurrently, which they have named the "Turner Switch" technique in honor of its inventor. METHODS: The authors conducted a retrospective analysis of cases of infected IDDDs in which patients underwent simultaneous explantation of the infected pump and implantation of a new pump. Demographics and clinical data were collected. RESULTS: Data from a total of 17 patients (11 male, 6 female) who underwent simultaneous IDDD explantation and implantation to treat infections were analyzed from a 3-year period. No patients experienced infection of the newly implanted pump or catheter. Of the 17 patients, 14 (82.4%) had baclofen pumps to treat spasticity and 3 (17.6%) had fentanyl pumps to treat chronic pain. The median hospital stay was 7 days, with 16 of 17 (94.1%) patients able to be discharged home or to a facility with a level of care similar to their preoperative care. All patients ultimately experienced complete resolution of their initial infections. Five patients (29.4%) required a return to the operating room within the next 5 months (for repair of a CSF leak in 2 cases, for treatment of infection at the old pump site in 2 cases, and for treatment of a CSF leak compounded with infection in 1 case). No patient experienced infection of the newly implanted pump or catheter. CONCLUSIONS: IDDD infections represent a large portion of morbidity associated with these devices. The current standard of care for deep pump infections requires pump explantation and a course of antibiotics prior to reimplantation of the IDDD. The authors demonstrate the effectiveness of a procedure involving simultaneous explantation of an infected pump and implantation of a new pump on the contralateral side in the treatment of IDDD infections.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Leibold AT, Weyhenmeyer J, Lee A, et al. Simultaneous explantation and implantation of intrathecal pumps: a case series. J Neurosurg. 2019. PMID: 30978693. doi:10.3171/2019.1.JNS18919

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。